

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.57192847 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.57192847 |
| 3 | cellular response to leptin stimulus (GO:0044320) | 7.30709168 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.25429447 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.25429447 |
| 6 | fatty acid elongation (GO:0030497) | 6.92734750 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.86560236 |
| 8 | regulation of cilium movement (GO:0003352) | 6.40073593 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.23051131 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.23051131 |
| 11 | tryptophan catabolic process (GO:0006569) | 6.23051131 |
| 12 | very long-chain fatty acid metabolic process (GO:0000038) | 6.10101727 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.04221938 |
| 14 | kynurenine metabolic process (GO:0070189) | 6.01113831 |
| 15 | response to leptin (GO:0044321) | 5.98332405 |
| 16 | artery smooth muscle contraction (GO:0014824) | 5.90808849 |
| 17 | bile acid biosynthetic process (GO:0006699) | 5.87467016 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.86123753 |
| 19 | tryptophan metabolic process (GO:0006568) | 5.85517910 |
| 20 | urea metabolic process (GO:0019627) | 5.55996825 |
| 21 | urea cycle (GO:0000050) | 5.55996825 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 5.53511176 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 5.51678243 |
| 24 | cysteine metabolic process (GO:0006534) | 5.48730432 |
| 25 | high-density lipoprotein particle remodeling (GO:0034375) | 5.31500415 |
| 26 | negative regulation of fibrinolysis (GO:0051918) | 5.30567702 |
| 27 | epoxygenase P450 pathway (GO:0019373) | 5.25677452 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 5.17403697 |
| 29 | tonic smooth muscle contraction (GO:0014820) | 5.16957700 |
| 30 | complement activation, alternative pathway (GO:0006957) | 5.16445506 |
| 31 | protein carboxylation (GO:0018214) | 5.13202601 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.13202601 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 5.12593771 |
| 34 | regulation of fibrinolysis (GO:0051917) | 5.10137463 |
| 35 | negative regulation of appetite (GO:0032099) | 5.08215830 |
| 36 | negative regulation of response to food (GO:0032096) | 5.08215830 |
| 37 | regulation of protein activation cascade (GO:2000257) | 5.07573600 |
| 38 | alkaloid metabolic process (GO:0009820) | 5.04953870 |
| 39 | bile acid metabolic process (GO:0008206) | 5.04277674 |
| 40 | C4-dicarboxylate transport (GO:0015740) | 5.00815383 |
| 41 | aromatic amino acid family metabolic process (GO:0009072) | 4.99033269 |
| 42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.95652398 |
| 43 | homocysteine metabolic process (GO:0050667) | 4.94835013 |
| 44 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.86821373 |
| 45 | linoleic acid metabolic process (GO:0043651) | 4.85201640 |
| 46 | lysine metabolic process (GO:0006553) | 4.81647352 |
| 47 | lysine catabolic process (GO:0006554) | 4.81647352 |
| 48 | tyrosine metabolic process (GO:0006570) | 4.76896512 |
| 49 | ovulation cycle (GO:0042698) | 4.76199686 |
| 50 | regulation of complement activation (GO:0030449) | 4.75458765 |
| 51 | regulation of triglyceride catabolic process (GO:0010896) | 4.72010410 |
| 52 | cellular ketone body metabolic process (GO:0046950) | 4.71059011 |
| 53 | omega-hydroxylase P450 pathway (GO:0097267) | 4.69841702 |
| 54 | alpha-amino acid catabolic process (GO:1901606) | 4.65917248 |
| 55 | regulation of cholesterol esterification (GO:0010872) | 4.65873462 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 4.65357069 |
| 57 | drug metabolic process (GO:0017144) | 4.61417724 |
| 58 | reverse cholesterol transport (GO:0043691) | 4.60920920 |
| 59 | lipopolysaccharide biosynthetic process (GO:0009103) | 4.57460504 |
| 60 | protein-lipid complex remodeling (GO:0034368) | 4.56338229 |
| 61 | macromolecular complex remodeling (GO:0034367) | 4.56338229 |
| 62 | plasma lipoprotein particle remodeling (GO:0034369) | 4.56338229 |
| 63 | negative regulation of cholesterol transport (GO:0032375) | 4.54037920 |
| 64 | negative regulation of sterol transport (GO:0032372) | 4.54037920 |
| 65 | bile acid and bile salt transport (GO:0015721) | 4.50329051 |
| 66 | acylglycerol homeostasis (GO:0055090) | 4.48509489 |
| 67 | triglyceride homeostasis (GO:0070328) | 4.48509489 |
| 68 | nonmotile primary cilium assembly (GO:0035058) | 4.43928131 |
| 69 | indolalkylamine metabolic process (GO:0006586) | 4.40782882 |
| 70 | phospholipid efflux (GO:0033700) | 4.40768372 |
| 71 | cellular glucuronidation (GO:0052695) | 4.38973266 |
| 72 | coenzyme catabolic process (GO:0009109) | 4.37089919 |
| 73 | cellular amino acid catabolic process (GO:0009063) | 4.32528887 |
| 74 | glycine metabolic process (GO:0006544) | 4.32012384 |
| 75 | cellular biogenic amine catabolic process (GO:0042402) | 4.30747157 |
| 76 | amine catabolic process (GO:0009310) | 4.30747157 |
| 77 | signal peptide processing (GO:0006465) | 4.28228762 |
| 78 | glutamate metabolic process (GO:0006536) | 4.26566036 |
| 79 | serine family amino acid metabolic process (GO:0009069) | 4.23835076 |
| 80 | drug catabolic process (GO:0042737) | 4.21632429 |
| 81 | striatum development (GO:0021756) | 4.21347260 |
| 82 | benzene-containing compound metabolic process (GO:0042537) | 4.19090977 |
| 83 | plasma lipoprotein particle clearance (GO:0034381) | 4.18104464 |
| 84 | imidazole-containing compound metabolic process (GO:0052803) | 4.16919732 |
| 85 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 4.15317717 |
| 86 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 4.14946767 |
| 87 | cellular modified amino acid catabolic process (GO:0042219) | 4.14604210 |
| 88 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.08630447 |
| 89 | ethanol oxidation (GO:0006069) | 4.08333308 |
| 90 | ketone body metabolic process (GO:1902224) | 4.08061573 |
| 91 | regulation of protein glycosylation (GO:0060049) | 4.06818094 |
| 92 | neurotransmitter uptake (GO:0001504) | 4.03410723 |
| 93 | serine family amino acid biosynthetic process (GO:0009070) | 4.01534471 |
| 94 | regulation of response to food (GO:0032095) | 4.00625464 |
| 95 | cholesterol efflux (GO:0033344) | 4.00065278 |
| 96 | lipopolysaccharide metabolic process (GO:0008653) | 4.00060402 |
| 97 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.97923324 |
| 98 | aldehyde catabolic process (GO:0046185) | 3.96489972 |
| 99 | arginine metabolic process (GO:0006525) | 3.96250621 |
| 100 | glucuronate metabolic process (GO:0019585) | 3.92876285 |
| 101 | uronic acid metabolic process (GO:0006063) | 3.92876285 |
| 102 | oxidative demethylation (GO:0070989) | 3.89081385 |
| 103 | short-chain fatty acid metabolic process (GO:0046459) | 3.86544266 |
| 104 | regulation of relaxation of muscle (GO:1901077) | 3.83653508 |
| 105 | fibrinolysis (GO:0042730) | 3.83136720 |
| 106 | plasma lipoprotein particle assembly (GO:0034377) | 3.82337685 |
| 107 | drug transmembrane transport (GO:0006855) | 3.80650758 |
| 108 | carboxylic acid catabolic process (GO:0046395) | 3.80017834 |
| 109 | organic acid catabolic process (GO:0016054) | 3.80017834 |
| 110 | low-density lipoprotein particle remodeling (GO:0034374) | 3.79206228 |
| 111 | regulation of bile acid biosynthetic process (GO:0070857) | 3.78121895 |
| 112 | L-amino acid import (GO:0043092) | 3.77763058 |
| 113 | acetyl-CoA metabolic process (GO:0006084) | 3.77333933 |
| 114 | brain morphogenesis (GO:0048854) | 3.77320176 |
| 115 | exogenous drug catabolic process (GO:0042738) | 3.76971474 |
| 116 | regulation of actin filament-based movement (GO:1903115) | 3.76217223 |
| 117 | cofactor catabolic process (GO:0051187) | 3.72188167 |
| 118 | regulation of cholesterol homeostasis (GO:2000188) | 3.70558639 |
| 119 | urate metabolic process (GO:0046415) | 3.70219184 |
| 120 | cholesterol homeostasis (GO:0042632) | 3.67937764 |
| 121 | flavonoid metabolic process (GO:0009812) | 3.67885194 |
| 122 | regulation of microtubule-based movement (GO:0060632) | 3.67356273 |
| 123 | phospholipid homeostasis (GO:0055091) | 3.67007121 |
| 124 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.66642744 |
| 125 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.66642744 |
| 126 | sterol homeostasis (GO:0055092) | 3.62722131 |
| 127 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.62682781 |
| 128 | positive regulation of lipid catabolic process (GO:0050996) | 3.62444092 |
| 129 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.62410846 |
| 130 | negative regulation of lipase activity (GO:0060192) | 3.61782985 |
| 131 | blood coagulation, intrinsic pathway (GO:0007597) | 3.60981510 |
| 132 | vascular smooth muscle contraction (GO:0014829) | 3.60210230 |
| 133 | complement activation, classical pathway (GO:0006958) | 3.59291287 |
| 134 | complement activation (GO:0006956) | 3.56234745 |
| 135 | NAD biosynthetic process (GO:0009435) | 3.55902398 |
| 136 | aspartate family amino acid catabolic process (GO:0009068) | 3.54730535 |
| 137 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.46131139 |
| 138 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.39704529 |
| 139 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.38809804 |
| 140 | xenobiotic catabolic process (GO:0042178) | 3.37721096 |
| 141 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.30950925 |
| 142 | regulation of cell communication by electrical coupling (GO:0010649) | 3.30307732 |
| 143 | branched-chain amino acid catabolic process (GO:0009083) | 3.28942161 |
| 144 | hyperosmotic salinity response (GO:0042538) | 3.25981663 |
| 145 | response to misfolded protein (GO:0051788) | 3.17363634 |
| 146 | phenylpropanoid metabolic process (GO:0009698) | 3.16195133 |
| 147 | tricarboxylic acid cycle (GO:0006099) | 3.15141549 |
| 148 | respiratory tube development (GO:0030323) | 3.14122126 |
| 149 | renal absorption (GO:0070293) | 3.12082413 |
| 150 | one-carbon compound transport (GO:0019755) | 3.10359884 |
| 151 | tetrahydrofolate metabolic process (GO:0046653) | 3.08738997 |
| 152 | regulation of appetite (GO:0032098) | 3.00293252 |
| 153 | carnitine metabolic process (GO:0009437) | 3.00099524 |
| 154 | daunorubicin metabolic process (GO:0044597) | 2.99791194 |
| 155 | polyketide metabolic process (GO:0030638) | 2.99791194 |
| 156 | doxorubicin metabolic process (GO:0044598) | 2.99791194 |
| 157 | acyl-CoA biosynthetic process (GO:0071616) | 2.99423311 |
| 158 | thioester biosynthetic process (GO:0035384) | 2.99423311 |
| 159 | negative regulation of multicellular organism growth (GO:0040015) | 2.99106278 |
| 160 | regulation of cholesterol metabolic process (GO:0090181) | 2.97818980 |
| 161 | amino acid import (GO:0043090) | 2.94596847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.32069482 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.14631101 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.81575330 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.41978129 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.22259431 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.98590415 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.91866977 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.97214655 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.88108388 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.29901377 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.97409662 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.35103925 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.22210163 |
| 14 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.13928739 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.10904375 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.09173857 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05886902 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.03404953 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7855427 |
| 20 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.75525851 |
| 21 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.66791701 |
| 22 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58824805 |
| 23 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58612902 |
| 24 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.56166622 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.53621294 |
| 26 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.48533687 |
| 27 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.48490724 |
| 28 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.46883653 |
| 29 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.43690794 |
| 30 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.42959428 |
| 31 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.42681381 |
| 32 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.42266732 |
| 33 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.42192291 |
| 34 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.41658882 |
| 35 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38204121 |
| 36 | CJUN_26792858_Chip-Seq_BT549_Human | 1.37026146 |
| 37 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.34825821 |
| 38 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.30141039 |
| 39 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28181645 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27692839 |
| 41 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.26544533 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.25545457 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23278154 |
| 44 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.20922571 |
| 45 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17303943 |
| 46 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.16164422 |
| 47 | TCF4_23295773_ChIP-Seq_U87_Human | 1.15745368 |
| 48 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.12908866 |
| 49 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10892211 |
| 50 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.10572401 |
| 51 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.10512827 |
| 52 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.09834821 |
| 53 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.09325682 |
| 54 | STAT3_23295773_ChIP-Seq_U87_Human | 1.08668193 |
| 55 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.08537841 |
| 56 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.07672909 |
| 57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.05577364 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.05433952 |
| 59 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.04404997 |
| 60 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.04404997 |
| 61 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.04381066 |
| 62 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02511729 |
| 63 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.01732944 |
| 64 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.01732944 |
| 65 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99206302 |
| 66 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99206302 |
| 67 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.98669740 |
| 68 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.97661281 |
| 69 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.95995049 |
| 70 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95903344 |
| 71 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.95342142 |
| 72 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.95265082 |
| 73 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.94499439 |
| 74 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.94348125 |
| 75 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93880383 |
| 76 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.93504167 |
| 77 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93477506 |
| 78 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.92974258 |
| 79 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.92899413 |
| 80 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91553245 |
| 81 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.90669852 |
| 82 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.90398752 |
| 83 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.85133079 |
| 84 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84815887 |
| 85 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.83109276 |
| 86 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.82878630 |
| 87 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.82410709 |
| 88 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.82204906 |
| 89 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.82031726 |
| 90 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81833759 |
| 91 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80764664 |
| 92 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.80279293 |
| 93 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.79752315 |
| 94 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.79640430 |
| 95 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.79527385 |
| 96 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.79034514 |
| 97 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78576152 |
| 98 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.78274287 |
| 99 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77947389 |
| 100 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.77921228 |
| 101 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.77791996 |
| 102 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.77759686 |
| 103 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77257907 |
| 104 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.75524998 |
| 105 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.75109517 |
| 106 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74870912 |
| 107 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.73535447 |
| 108 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71900848 |
| 109 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.70905073 |
| 110 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.69845800 |
| 111 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.69782378 |
| 112 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.69617922 |
| 113 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69225753 |
| 114 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69031960 |
| 115 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66130603 |
| 116 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66130603 |
| 117 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66118325 |
| 118 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63051898 |
| 119 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.62886503 |
| 120 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.61768426 |
| 121 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.59703145 |
| 122 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.59613059 |
| 123 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58534977 |
| 124 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.57539383 |
| 125 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.56270238 |
| 126 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.56147049 |
| 127 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.55587138 |
| 128 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.55200271 |
| 129 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51756388 |
| 130 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.51195541 |
| 131 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50142837 |
| 132 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.49442521 |
| 133 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.49150557 |
| 134 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48606679 |
| 135 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47188613 |
| 136 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.47066394 |
| 137 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46975768 |
| 138 | CBP_21632823_ChIP-Seq_H3396_Human | 0.46375530 |
| 139 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.46171653 |
| 140 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46150971 |
| 141 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.45787220 |
| 142 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.45486396 |
| 143 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.44591594 |
| 144 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.44293340 |
| 145 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44120452 |
| 146 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.42812853 |
| 147 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42424881 |
| 148 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.42084352 |
| 149 | GATA1_19941826_ChIP-Seq_K562_Human | 0.41563526 |
| 150 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.40905669 |
| 151 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.40019995 |
| 152 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.39206211 |
| 153 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39047729 |
| 154 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.37876842 |
| 155 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37728140 |
| 156 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.36951999 |
| 157 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.36811703 |
| 158 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.36810370 |
| 159 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.36796872 |
| 160 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.36470924 |
| 161 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.36392877 |
| 162 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.36188781 |
| 163 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.36067922 |
| 164 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.35335409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.28961316 |
| 2 | MP0005360_urolithiasis | 7.64491331 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.40355331 |
| 4 | MP0005365_abnormal_bile_salt | 6.12740715 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.22472875 |
| 6 | MP0001984_abnormal_olfaction | 5.03766869 |
| 7 | MP0002736_abnormal_nociception_after | 4.35482051 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 4.07415756 |
| 9 | MP0003252_abnormal_bile_duct | 3.97601808 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.46384154 |
| 11 | MP0005423_abnormal_somatic_nervous | 3.41518287 |
| 12 | MP0009840_abnormal_foam_cell | 3.13613444 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.97194673 |
| 14 | MP0005083_abnormal_biliary_tract | 2.92634849 |
| 15 | MP0005332_abnormal_amino_acid | 2.90395662 |
| 16 | MP0003195_calcinosis | 2.86953993 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.64252009 |
| 18 | MP0003880_abnormal_central_pattern | 2.55526716 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.36329474 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.32159954 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.12665996 |
| 22 | MP0000609_abnormal_liver_physiology | 2.11225676 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 2.08033899 |
| 24 | MP0005551_abnormal_eye_electrophysiolog | 1.98685537 |
| 25 | MP0003868_abnormal_feces_composition | 1.93769460 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.83004989 |
| 27 | MP0002734_abnormal_mechanical_nocicepti | 1.82590759 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.74607288 |
| 29 | MP0005310_abnormal_salivary_gland | 1.73064697 |
| 30 | MP0000751_myopathy | 1.70398573 |
| 31 | MP0004215_abnormal_myocardial_fiber | 1.67154261 |
| 32 | MP0001764_abnormal_homeostasis | 1.64154538 |
| 33 | MP0001486_abnormal_startle_reflex | 1.62102777 |
| 34 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.58466469 |
| 35 | MP0004147_increased_porphyrin_level | 1.56692972 |
| 36 | MP0005451_abnormal_body_composition | 1.53179661 |
| 37 | MP0001986_abnormal_taste_sensitivity | 1.51723658 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.42702045 |
| 39 | MP0009697_abnormal_copulation | 1.40007770 |
| 40 | MP0003186_abnormal_redox_activity | 1.30724647 |
| 41 | MP0003011_delayed_dark_adaptation | 1.30513712 |
| 42 | MP0000538_abnormal_urinary_bladder | 1.24037370 |
| 43 | MP0001905_abnormal_dopamine_level | 1.19337600 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.16257881 |
| 45 | MP0001970_abnormal_pain_threshold | 1.15992058 |
| 46 | MP0000749_muscle_degeneration | 1.14883601 |
| 47 | MP0000598_abnormal_liver_morphology | 1.14574361 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 1.12240660 |
| 49 | MP0001853_heart_inflammation | 1.11462114 |
| 50 | MP0005647_abnormal_sex_gland | 1.09114903 |
| 51 | MP0005636_abnormal_mineral_homeostasis | 1.08162535 |
| 52 | MP0008260_abnormal_autophagy | 1.07487541 |
| 53 | MP0009764_decreased_sensitivity_to | 1.02764052 |
| 54 | MP0000343_altered_response_to | 1.01962760 |
| 55 | MP0003136_yellow_coat_color | 1.00636132 |
| 56 | MP0000604_amyloidosis | 0.99019091 |
| 57 | MP0004233_abnormal_muscle_weight | 0.96301144 |
| 58 | MP0004272_abnormal_basement_membrane | 0.96027419 |
| 59 | MP0009763_increased_sensitivity_to | 0.95040771 |
| 60 | MP0002254_reproductive_system_inflammat | 0.92178465 |
| 61 | MP0008775_abnormal_heart_ventricle | 0.89515309 |
| 62 | MP0008469_abnormal_protein_level | 0.87325013 |
| 63 | MP0009642_abnormal_blood_homeostasis | 0.87276750 |
| 64 | MP0005253_abnormal_eye_physiology | 0.85834995 |
| 65 | MP0005670_abnormal_white_adipose | 0.84657416 |
| 66 | MP0006036_abnormal_mitochondrial_physio | 0.83498405 |
| 67 | MP0005084_abnormal_gallbladder_morpholo | 0.83399641 |
| 68 | MP0002876_abnormal_thyroid_physiology | 0.82107357 |
| 69 | MP0005408_hypopigmentation | 0.80656360 |
| 70 | MP0002653_abnormal_ependyma_morphology | 0.80008102 |
| 71 | MP0002272_abnormal_nervous_system | 0.79277531 |
| 72 | MP0008789_abnormal_olfactory_epithelium | 0.79204541 |
| 73 | MP0010368_abnormal_lymphatic_system | 0.78791501 |
| 74 | MP0005376_homeostasis/metabolism_phenot | 0.77290124 |
| 75 | MP0001756_abnormal_urination | 0.75936511 |
| 76 | MP0002078_abnormal_glucose_homeostasis | 0.75272922 |
| 77 | MP0009765_abnormal_xenobiotic_induced | 0.75210781 |
| 78 | MP0005023_abnormal_wound_healing | 0.75072604 |
| 79 | MP0001485_abnormal_pinna_reflex | 0.73019870 |
| 80 | MP0002822_catalepsy | 0.72004290 |
| 81 | MP0005220_abnormal_exocrine_pancreas | 0.70899313 |
| 82 | MP0002733_abnormal_thermal_nociception | 0.70750303 |
| 83 | MP0002971_abnormal_brown_adipose | 0.69507226 |
| 84 | MP0004036_abnormal_muscle_relaxation | 0.68198478 |
| 85 | MP0005535_abnormal_body_temperature | 0.67262119 |
| 86 | MP0005334_abnormal_fat_pad | 0.65929820 |
| 87 | MP0004130_abnormal_muscle_cell | 0.64823119 |
| 88 | MP0009053_abnormal_anal_canal | 0.64776584 |
| 89 | MP0003633_abnormal_nervous_system | 0.64582030 |
| 90 | MP0001661_extended_life_span | 0.64320033 |
| 91 | MP0005266_abnormal_metabolism | 0.63718158 |
| 92 | MP0003690_abnormal_glial_cell | 0.61379711 |
| 93 | MP0001664_abnormal_digestion | 0.60981520 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.59992894 |
| 95 | MP0001529_abnormal_vocalization | 0.59268774 |
| 96 | MP0002090_abnormal_vision | 0.58239984 |
| 97 | MP0003329_amyloid_beta_deposits | 0.58184670 |
| 98 | MP0004270_analgesia | 0.57813461 |
| 99 | MP0006035_abnormal_mitochondrial_morpho | 0.57441722 |
| 100 | MP0001963_abnormal_hearing_physiology | 0.56216617 |
| 101 | MP0002132_abnormal_respiratory_system | 0.55878326 |
| 102 | MP0008058_abnormal_DNA_repair | 0.55670255 |
| 103 | MP0005448_abnormal_energy_balance | 0.52489653 |
| 104 | MP0002928_abnormal_bile_duct | 0.51518634 |
| 105 | MP0000639_abnormal_adrenal_gland | 0.51479547 |
| 106 | MP0005164_abnormal_response_to | 0.50451316 |
| 107 | MP0005395_other_phenotype | 0.49095746 |
| 108 | MP0004043_abnormal_pH_regulation | 0.48806524 |
| 109 | MP0003638_abnormal_response/metabolism_ | 0.48540332 |
| 110 | MP0010234_abnormal_vibrissa_follicle | 0.46477370 |
| 111 | MP0008873_increased_physiological_sensi | 0.45062057 |
| 112 | MP0003718_maternal_effect | 0.44410432 |
| 113 | MP0005464_abnormal_platelet_physiology | 0.44366902 |
| 114 | MP0002796_impaired_skin_barrier | 0.43329006 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.42787351 |
| 116 | MP0008874_decreased_physiological_sensi | 0.42388513 |
| 117 | MP0003724_increased_susceptibility_to | 0.42271758 |
| 118 | MP0004782_abnormal_surfactant_physiolog | 0.41687065 |
| 119 | MP0003953_abnormal_hormone_level | 0.41224908 |
| 120 | MP0005166_decreased_susceptibility_to | 0.40418622 |
| 121 | MP0003075_altered_response_to | 0.39421699 |
| 122 | MP0001765_abnormal_ion_homeostasis | 0.38662517 |
| 123 | MP0008872_abnormal_physiological_respon | 0.38455716 |
| 124 | MP0000230_abnormal_systemic_arterial | 0.38184825 |
| 125 | MP0003436_decreased_susceptibility_to | 0.36914528 |
| 126 | MP0002837_dystrophic_cardiac_calcinosis | 0.36336753 |
| 127 | MP0009672_abnormal_birth_weight | 0.35999841 |
| 128 | MP0009384_cardiac_valve_regurgitation | 0.35754381 |
| 129 | MP0005248_abnormal_Harderian_gland | 0.35098224 |
| 130 | MP0002168_other_aberrant_phenotype | 0.34746526 |
| 131 | MP0005058_abnormal_lysosome_morphology | 0.34645553 |
| 132 | MP0004381_abnormal_hair_follicle | 0.33850403 |
| 133 | MP0004264_abnormal_extraembryonic_tissu | 0.33215389 |
| 134 | MP0000579_abnormal_nail_morphology | 0.32220555 |
| 135 | MP0005167_abnormal_blood-brain_barrier | 0.32155357 |
| 136 | MP0009115_abnormal_fat_cell | 0.30612449 |
| 137 | MP0000249_abnormal_blood_vessel | 0.29449733 |
| 138 | MP0006082_CNS_inflammation | 0.28897903 |
| 139 | MP0001845_abnormal_inflammatory_respons | 0.28769725 |
| 140 | MP0002970_abnormal_white_adipose | 0.28054354 |
| 141 | MP0001243_abnormal_dermal_layer | 0.27051564 |
| 142 | MP0004883_abnormal_blood_vessel | 0.26857980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.35913681 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.17435903 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.07195954 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.61608968 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.22030012 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.21095080 |
| 7 | Xanthomatosis (HP:0000991) | 6.18600883 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.43206861 |
| 9 | Congenital primary aphakia (HP:0007707) | 5.19941955 |
| 10 | Complement deficiency (HP:0004431) | 5.12217474 |
| 11 | Gait imbalance (HP:0002141) | 5.10047708 |
| 12 | Hyperammonemia (HP:0001987) | 4.65815572 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.63384966 |
| 14 | Joint hemorrhage (HP:0005261) | 4.56400560 |
| 15 | Nephrogenic diabetes insipidus (HP:0009806) | 4.54739983 |
| 16 | Medial flaring of the eyebrow (HP:0010747) | 4.52271496 |
| 17 | Hyperglycinemia (HP:0002154) | 4.43629141 |
| 18 | Epidermoid cyst (HP:0200040) | 4.42846980 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.42308602 |
| 20 | Ketosis (HP:0001946) | 4.35211634 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.29990098 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.24955722 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.23652999 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 4.19915354 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 4.14938870 |
| 26 | Hyperglycinuria (HP:0003108) | 4.14818971 |
| 27 | Fat malabsorption (HP:0002630) | 4.06824340 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 4.05128578 |
| 29 | Abnormality of glycine metabolism (HP:0010895) | 4.04712819 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.04712819 |
| 31 | Hypoglycemic coma (HP:0001325) | 3.82947234 |
| 32 | Poor coordination (HP:0002370) | 3.82394734 |
| 33 | Hemiplegia (HP:0002301) | 3.79930272 |
| 34 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.76772806 |
| 35 | Abnormality of complement system (HP:0005339) | 3.72940813 |
| 36 | Conjugated hyperbilirubinemia (HP:0002908) | 3.67357297 |
| 37 | Abnormality of the intrinsic pathway (HP:0010989) | 3.54069035 |
| 38 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.50121128 |
| 39 | Hypercholesterolemia (HP:0003124) | 3.45684194 |
| 40 | Action tremor (HP:0002345) | 3.45548451 |
| 41 | Abnormality of glycolysis (HP:0004366) | 3.44418057 |
| 42 | Vaginal atresia (HP:0000148) | 3.43817185 |
| 43 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.38428416 |
| 44 | Genital tract atresia (HP:0001827) | 3.30957385 |
| 45 | Hyperbilirubinemia (HP:0002904) | 3.28401679 |
| 46 | Abnormality of nucleobase metabolism (HP:0010932) | 3.21684206 |
| 47 | Ketoacidosis (HP:0001993) | 3.14754201 |
| 48 | Delayed CNS myelination (HP:0002188) | 3.12913628 |
| 49 | Abnormality of serum amino acid levels (HP:0003112) | 3.05786296 |
| 50 | Steatorrhea (HP:0002570) | 3.05509892 |
| 51 | Increased serum pyruvate (HP:0003542) | 2.98184585 |
| 52 | Hepatocellular carcinoma (HP:0001402) | 2.95511472 |
| 53 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.95256850 |
| 54 | Abnormality of purine metabolism (HP:0004352) | 2.94139907 |
| 55 | Gout (HP:0001997) | 2.92431839 |
| 56 | Bile duct proliferation (HP:0001408) | 2.89720324 |
| 57 | Abnormal biliary tract physiology (HP:0012439) | 2.89720324 |
| 58 | Left ventricular hypertrophy (HP:0001712) | 2.88567830 |
| 59 | Metabolic acidosis (HP:0001942) | 2.86592233 |
| 60 | Myocardial infarction (HP:0001658) | 2.83386674 |
| 61 | Spontaneous abortion (HP:0005268) | 2.80356841 |
| 62 | Hemiparesis (HP:0001269) | 2.80089381 |
| 63 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.77811661 |
| 64 | Dicarboxylic aciduria (HP:0003215) | 2.77811661 |
| 65 | CNS demyelination (HP:0007305) | 2.73901970 |
| 66 | Hepatocellular necrosis (HP:0001404) | 2.72983187 |
| 67 | Lethargy (HP:0001254) | 2.72257760 |
| 68 | Hypochromic microcytic anemia (HP:0004840) | 2.71993557 |
| 69 | Skin nodule (HP:0200036) | 2.69953024 |
| 70 | Vascular calcification (HP:0004934) | 2.67491173 |
| 71 | Systemic lupus erythematosus (HP:0002725) | 2.64260953 |
| 72 | Cerebral edema (HP:0002181) | 2.49946954 |
| 73 | Hepatic necrosis (HP:0002605) | 2.46419865 |
| 74 | Spastic diplegia (HP:0001264) | 2.45452049 |
| 75 | Irritability (HP:0000737) | 2.43946739 |
| 76 | Acanthocytosis (HP:0001927) | 2.43663534 |
| 77 | Neonatal onset (HP:0003623) | 2.41286803 |
| 78 | Hypoglycemic seizures (HP:0002173) | 2.40277111 |
| 79 | Abnormality of vitamin metabolism (HP:0100508) | 2.37447420 |
| 80 | Malnutrition (HP:0004395) | 2.37412092 |
| 81 | Cardiovascular calcification (HP:0011915) | 2.36912253 |
| 82 | Methylmalonic aciduria (HP:0012120) | 2.36859661 |
| 83 | Abnormal gallbladder morphology (HP:0012437) | 2.36009738 |
| 84 | Tetraplegia (HP:0002445) | 2.35261058 |
| 85 | Broad foot (HP:0001769) | 2.34307052 |
| 86 | Mitral stenosis (HP:0001718) | 2.32412660 |
| 87 | Cholecystitis (HP:0001082) | 2.30466781 |
| 88 | Abnormal gallbladder physiology (HP:0012438) | 2.30466781 |
| 89 | Cholelithiasis (HP:0001081) | 2.29591948 |
| 90 | Glomerulonephritis (HP:0000099) | 2.28357556 |
| 91 | Generalized aminoaciduria (HP:0002909) | 2.27737918 |
| 92 | Sensorimotor neuropathy (HP:0007141) | 2.24784998 |
| 93 | Alkalosis (HP:0001948) | 2.24382660 |
| 94 | Confusion (HP:0001289) | 2.23735964 |
| 95 | Nephritis (HP:0000123) | 2.22002309 |
| 96 | Enlarged kidneys (HP:0000105) | 2.20726196 |
| 97 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.20026771 |
| 98 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.19540786 |
| 99 | Exercise-induced myalgia (HP:0003738) | 2.19452553 |
| 100 | Vomiting (HP:0002013) | 2.19268749 |
| 101 | Esophageal varix (HP:0002040) | 2.18338970 |
| 102 | Late onset (HP:0003584) | 2.18323979 |
| 103 | Pancreatitis (HP:0001733) | 2.17942761 |
| 104 | Amyloidosis (HP:0011034) | 2.13193281 |
| 105 | Insidious onset (HP:0003587) | 2.12562879 |
| 106 | Termporal pattern (HP:0011008) | 2.12562879 |
| 107 | Brushfield spots (HP:0001088) | 2.11653208 |
| 108 | Rickets (HP:0002748) | 2.10113806 |
| 109 | Methylmalonic acidemia (HP:0002912) | 2.09273178 |
| 110 | Abnormal glucose tolerance (HP:0001952) | 2.05700665 |
| 111 | Abnormal cartilage morphology (HP:0002763) | 2.05193632 |
| 112 | Abnormality of proline metabolism (HP:0010907) | 2.04865048 |
| 113 | Hydroxyprolinuria (HP:0003080) | 2.04865048 |
| 114 | Ulnar claw (HP:0001178) | 2.04409861 |
| 115 | Hyperuricemia (HP:0002149) | 2.03264068 |
| 116 | Increased purine levels (HP:0004368) | 2.03264068 |
| 117 | Proximal tubulopathy (HP:0000114) | 2.03241014 |
| 118 | Type I transferrin isoform profile (HP:0003642) | 2.02958859 |
| 119 | Menorrhagia (HP:0000132) | 2.02580838 |
| 120 | Gingival bleeding (HP:0000225) | 2.02518399 |
| 121 | Abnormality of vitamin B metabolism (HP:0004340) | 2.00713967 |
| 122 | Opisthotonus (HP:0002179) | 1.99487775 |
| 123 | Thrombophlebitis (HP:0004418) | 1.98026101 |
| 124 | Abnormality of the gallbladder (HP:0005264) | 1.96297701 |
| 125 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93717364 |
| 126 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.92521051 |
| 127 | Azoospermia (HP:0000027) | 1.90039498 |
| 128 | Glycosuria (HP:0003076) | 1.89700346 |
| 129 | Abnormality of urine glucose concentration (HP:0011016) | 1.89700346 |
| 130 | Hemorrhage of the eye (HP:0011885) | 1.89339367 |
| 131 | Hypophosphatemic rickets (HP:0004912) | 1.88779932 |
| 132 | Acute encephalopathy (HP:0006846) | 1.88376057 |
| 133 | Spastic tetraparesis (HP:0001285) | 1.87942272 |
| 134 | Poikilocytosis (HP:0004447) | 1.87141552 |
| 135 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.85675312 |
| 136 | Renal cortical cysts (HP:0000803) | 1.84982219 |
| 137 | Abnormality of iron homeostasis (HP:0011031) | 1.82475956 |
| 138 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81811716 |
| 139 | Fatigue (HP:0012378) | 1.74351468 |
| 140 | Mitochondrial inheritance (HP:0001427) | 1.72064517 |
| 141 | Large for gestational age (HP:0001520) | 1.71679987 |
| 142 | Abnormality of the vocal cords (HP:0008777) | 1.71054543 |
| 143 | Abnormal spermatogenesis (HP:0008669) | 1.70082859 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK2 | 9.62758703 |
| 2 | BCKDK | 7.16182227 |
| 3 | FGFR4 | 4.37930485 |
| 4 | ERN1 | 4.26907336 |
| 5 | SIK1 | 4.25035407 |
| 6 | TAOK3 | 3.48379633 |
| 7 | STK16 | 3.26283412 |
| 8 | CCNB1 | 3.03360787 |
| 9 | EIF2AK1 | 2.98304929 |
| 10 | ERBB4 | 2.85776759 |
| 11 | INSRR | 2.83276611 |
| 12 | MST1R | 2.65704563 |
| 13 | NEK6 | 2.33294940 |
| 14 | MUSK | 2.31670947 |
| 15 | SRPK1 | 2.26045719 |
| 16 | MAP2K4 | 2.17567504 |
| 17 | PKN2 | 2.08742108 |
| 18 | MAPK11 | 1.86014661 |
| 19 | EIF2AK3 | 1.83530436 |
| 20 | FLT3 | 1.69885680 |
| 21 | FRK | 1.68691198 |
| 22 | PIK3CG | 1.65524924 |
| 23 | TNIK | 1.64486533 |
| 24 | TRIB3 | 1.62192743 |
| 25 | LATS1 | 1.57153368 |
| 26 | TYK2 | 1.54479404 |
| 27 | ABL2 | 1.52982388 |
| 28 | TNK2 | 1.48073886 |
| 29 | PTK6 | 1.47356790 |
| 30 | EPHA2 | 1.44424020 |
| 31 | MAP3K7 | 1.37573962 |
| 32 | DAPK2 | 1.32724235 |
| 33 | NEK9 | 1.30564405 |
| 34 | GRK6 | 1.27493020 |
| 35 | STK38L | 1.25627039 |
| 36 | FGFR2 | 1.25412169 |
| 37 | KDR | 1.23931079 |
| 38 | MKNK2 | 1.22289413 |
| 39 | PRKAA2 | 1.16196137 |
| 40 | TTK | 1.14943310 |
| 41 | JAK2 | 1.14405566 |
| 42 | PINK1 | 1.11920809 |
| 43 | CDK8 | 1.09300417 |
| 44 | MAPKAPK3 | 1.09223103 |
| 45 | TBK1 | 1.08128459 |
| 46 | PTK2B | 1.06527135 |
| 47 | ERBB2 | 1.04593410 |
| 48 | MAP3K14 | 1.02290718 |
| 49 | BMPR1B | 0.99663543 |
| 50 | LMTK2 | 0.97220771 |
| 51 | MET | 0.97167504 |
| 52 | MAP2K3 | 0.95937021 |
| 53 | MAPK4 | 0.95306774 |
| 54 | NTRK2 | 0.91908033 |
| 55 | PIK3CA | 0.91759257 |
| 56 | MAPK15 | 0.91659565 |
| 57 | PRKCZ | 0.91191514 |
| 58 | JAK1 | 0.88134187 |
| 59 | PRKCE | 0.86675754 |
| 60 | MAP3K10 | 0.86511691 |
| 61 | GRK7 | 0.86231835 |
| 62 | MAP3K3 | 0.85091614 |
| 63 | EPHB1 | 0.84042646 |
| 64 | PLK2 | 0.82233545 |
| 65 | RIPK1 | 0.80051627 |
| 66 | PRKG2 | 0.76388617 |
| 67 | TIE1 | 0.75893684 |
| 68 | PRKACG | 0.74998987 |
| 69 | CAMK2G | 0.74971766 |
| 70 | MAPK12 | 0.74501831 |
| 71 | LIMK1 | 0.74484704 |
| 72 | CAMK2B | 0.73734370 |
| 73 | GSK3A | 0.73371253 |
| 74 | CAMK2D | 0.73256234 |
| 75 | CSK | 0.72678269 |
| 76 | MAP3K11 | 0.72157577 |
| 77 | DYRK1B | 0.71388350 |
| 78 | MAP2K6 | 0.69943225 |
| 79 | PRKAA1 | 0.69190258 |
| 80 | SGK3 | 0.69099217 |
| 81 | CDK6 | 0.68911126 |
| 82 | PRKACB | 0.68839109 |
| 83 | CAMK1D | 0.66481250 |
| 84 | WNK4 | 0.65444262 |
| 85 | FER | 0.64038250 |
| 86 | PRKACA | 0.63723860 |
| 87 | PTK2 | 0.63393775 |
| 88 | PDPK1 | 0.63221293 |
| 89 | VRK2 | 0.62755638 |
| 90 | WNK3 | 0.59616477 |
| 91 | IRAK3 | 0.57837243 |
| 92 | EPHA3 | 0.57835252 |
| 93 | MAP2K2 | 0.57536529 |
| 94 | NME1 | 0.57393406 |
| 95 | ERBB3 | 0.55658616 |
| 96 | TGFBR2 | 0.55156533 |
| 97 | IKBKE | 0.54666984 |
| 98 | MAPK7 | 0.52573203 |
| 99 | CSNK2A1 | 0.51677098 |
| 100 | RPS6KA5 | 0.50976027 |
| 101 | PRKCQ | 0.50839091 |
| 102 | MAP2K1 | 0.50201884 |
| 103 | SGK494 | 0.49729684 |
| 104 | SGK223 | 0.49729684 |
| 105 | EPHB2 | 0.48930033 |
| 106 | SGK2 | 0.48568213 |
| 107 | CSNK1G1 | 0.45310625 |
| 108 | FGFR3 | 0.44991729 |
| 109 | CSF1R | 0.44386953 |
| 110 | TRPM7 | 0.43326954 |
| 111 | GRK1 | 0.42465334 |
| 112 | PDK4 | 0.41634707 |
| 113 | PDK3 | 0.41634707 |
| 114 | MKNK1 | 0.40836498 |
| 115 | IGF1R | 0.40104183 |
| 116 | ICK | 0.39956276 |
| 117 | PDK1 | 0.39420935 |
| 118 | DYRK1A | 0.39024558 |
| 119 | SGK1 | 0.38668209 |
| 120 | EPHA4 | 0.38128117 |
| 121 | MAPKAPK5 | 0.37138824 |
| 122 | PKN1 | 0.37040357 |
| 123 | MAP3K13 | 0.36960826 |
| 124 | OXSR1 | 0.36774739 |
| 125 | CAMK2A | 0.36747584 |
| 126 | CLK1 | 0.36454283 |
| 127 | TAOK2 | 0.36314494 |
| 128 | FGR | 0.35812062 |
| 129 | AKT2 | 0.35548950 |
| 130 | MAP3K5 | 0.34601884 |
| 131 | PRKDC | 0.34471857 |
| 132 | PRKCG | 0.33932471 |
| 133 | STK10 | 0.32919907 |
| 134 | MTOR | 0.32079454 |
| 135 | MAP3K1 | 0.32071107 |
| 136 | PBK | 0.31501159 |
| 137 | RET | 0.31315814 |
| 138 | SRC | 0.30976615 |
| 139 | ADRBK1 | 0.30855104 |
| 140 | PRKCA | 0.30669514 |
| 141 | PAK3 | 0.30390484 |
| 142 | CSNK1D | 0.29981294 |
| 143 | MYLK | 0.29804081 |
| 144 | INSR | 0.29313022 |
| 145 | EGFR | 0.29043955 |
| 146 | CDK4 | 0.28746380 |
| 147 | CSNK2A2 | 0.27324363 |
| 148 | MAP3K2 | 0.27126619 |
| 149 | LRRK2 | 0.26164796 |
| 150 | CAMK4 | 0.25383798 |
| 151 | NME2 | 0.25100685 |
| 152 | OBSCN | 0.24969662 |
| 153 | ROCK2 | 0.24208900 |
| 154 | PIM2 | 0.24050308 |
| 155 | ADRBK2 | 0.23720854 |
| 156 | MAP3K6 | 0.22868678 |
| 157 | NEK1 | 0.21465161 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.37860631 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.44677027 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.41399189 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.32521641 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.98508355 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70804243 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.66182346 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.64104333 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.57458419 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50734282 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50527758 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.44779550 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.33815251 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.28597269 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.13565344 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.12256370 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.98335942 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93730681 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91912434 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91022673 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90713217 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87893637 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.82033316 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.80318437 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.72615294 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72237985 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69128725 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.68880388 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.67045587 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66097739 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.64252292 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.60870661 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.56903824 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56785350 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.55707506 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55561866 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.43432004 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41499824 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.40792249 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33011225 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31407085 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30363797 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21465863 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18738339 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18189115 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16372963 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.15487488 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14628835 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.11439866 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09370622 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 1.01830215 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00580232 |
| 53 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.99843344 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98171825 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98140155 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92830066 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91279327 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86627267 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.84674551 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.80447617 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73349928 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73039902 |
| 63 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.72656284 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70025018 |
| 65 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67393430 |
| 66 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.59810742 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58218758 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.57940265 |
| 69 | Proteasome_Homo sapiens_hsa03050 | 0.57842630 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47996910 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47834821 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42165728 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31739572 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.31241572 |
| 75 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.29200798 |
| 76 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.29026157 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28982735 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28122624 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27722185 |
| 80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.26870264 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23051705 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.21227564 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20986909 |
| 84 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.20940236 |
| 85 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20547649 |
| 86 | Other glycan degradation_Homo sapiens_hsa00511 | 0.20053403 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16410859 |
| 88 | Parkinsons disease_Homo sapiens_hsa05012 | 0.10381585 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.09583401 |
| 90 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08426247 |
| 91 | Pertussis_Homo sapiens_hsa05133 | 0.05198463 |
| 92 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.02559223 |
| 93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01484738 |
| 94 | Alzheimers disease_Homo sapiens_hsa05010 | 0.01139313 |
| 95 | Homologous recombination_Homo sapiens_hsa03440 | 0.01062681 |
| 96 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.00728337 |
| 97 | Huntingtons disease_Homo sapiens_hsa05016 | 0.00111878 |
| 98 | Bladder cancer_Homo sapiens_hsa05219 | -0.2415451 |
| 99 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2382599 |
| 100 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2337160 |
| 101 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2286333 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1760620 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1721193 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1696562 |
| 105 | Hepatitis C_Homo sapiens_hsa05160 | -0.1654334 |
| 106 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1652355 |
| 107 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1642358 |
| 108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1590843 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | -0.1537644 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1371137 |
| 111 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1308414 |
| 112 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1304811 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1186910 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1151317 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1101968 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0811985 |
| 117 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0314009 |
| 118 | Nicotine addiction_Homo sapiens_hsa05033 | -0.0182884 |

